HuGE Literature Finder
Records
1
-
30
| Association between VKORC1 gene polymorphism and warfarin dose requirement and frequency of VKORC1 gene polymorphism in patients from Kerman province. The pharmacogenomics journal 2020 Jan . Soltani Banavandi Mohammad Javad, Satarzadeh Naghm |
| Warfarin dose requirement in patients having severe thrombosis or thrombophilia. British journal of clinical pharmacology 2019 Apr . Helin Tuukka A, Joutsi-Korhonen Lotta, Asmundela Heidi, Niemi Mikko, Orpana Arto, Lassila Riit |
| Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes. Medicine 2019 Feb 98 (6): e14365. Sr Kalpana, G Bharath, Jain Simran, Moorthy Nagaraja, Manjunath Satvic C, Christopher Ri |
| The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 Apr 34 (2): 328-336. Bedewy Ahmed M L, Showeta Salah, Mostafa Mostafa Hasan, Kandil Lamia Sae |
| Prevalence of common hereditary risk factors for thrombophilia in Somalia and identification of a novel Gln544Arg mutation in coagulation factor V. Journal of thrombosis and thrombolysis 2017 Sep . Abdi Abshir Ali, Osman Abdimaj |
| Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis : JTH 2017 Aug . Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer J H, Osterwalder J, Frauchiger B, Aschwanden M, Matter C M, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky |
| Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans. Journal of thrombosis and haemostasis : JTH 2017 Jan . Hernandez Wenndy, Gamazon Eric R, Aquino-Michaels Keston, Smithberger Erin, O'Brien Travis J, Harralson Arthur F, Tuck Matthew, Barbour April, Cavallari Larisa H, Perera Minoli |
| VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine 2016 Dec 95 (52): e5451. Misasi Silvia, Martini Giuliana, Paoletti Oriana, Calza Stefano, Scovoli Giovanni, Marengoni Alessandra, Testa Sophie, Caimi Luigi, Marchina Eleono |
| Identification of novel variants associated with warfarin stable dosage by use of a two-stage extreme phenotype strategy. Journal of thrombosis and haemostasis : JTH 2016 Oct . Luo Zhiying, Li Xi, Zhu Mingfeng, Tang Jie, Li Zhi, Zhou Xinming, Song Guobao, Liu Zhaoqian, Zhou Honghao, Zhang W |
| [FREQUENCY OF POLYMORPHISM OF VKORC1 AND CYP2C9 GENES IN TWO REGIONS OF GEORGIA]. Georgian medical news 2016 Jan (250): 46-51. Jokhadze T, Kakauridze N, Buadze T, Gaiozishvili M, Lezhava |
| High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
| Pharmacogenomic Testing and Warfarin Management. Oncology nursing forum 2015 Sep 42 (5): 563-5. Maluso Andr |
| The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2015 Jun 98 (6): 549-54. Sermsathanasawadi Nuttawut, Sritongsathian Chukij, Pongrattanaman Nunthapol, Praditsuktavorn Banjerd, Hongku Kiattisak, Wongwanit Chumpol, Ruangsetakit Chanean, Chinsakchai Khamin, Mutirangura Pramook, Poungvarin Narav |
| VKORC1 -1639 G>A Polymorphism in Romanian Patients With Deep Vein Thrombosis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 May . Vesa ?tefan Cristian, Trifa Adrian Pavel, Cri?an Sorin, Buzoianu Anca Da |
| Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study. Molecular diagnosis & therapy 2014 Dec 18 (6): 675-83. de Oliveira Almeida Vanessa Cristina, Ribeiro Daniel Dias, Gomes Karina Braga, Godard Ana Lúcia Brunial |
| Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH 2014 Sep 12 (9): 1480-7. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci P |
| VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2014 Jun . Azzam Hanan, Elwakeel Hossam, Awad Ibrahim, El-Farahaty Reham, El-Gilany Abdel-Hady, El-Sharawy Sola |
| An acenocoumarol dose algorithm based on a South-Eastern European population. European journal of clinical pharmacology 2013 Nov 69 (11): 1901-7. Pop Tudor Radu, Vesa ?tefan Cristian, Trifa Adrian Pavel, Cri?an Sorin, Buzoianu Anca Da |
| Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. Arthritis and rheumatism 2013 Jan 65 (1): 211-5. Kaiser Rachel, Taylor Kimberly E, Deng Yun, Zhao Jian, Li Yonghong, Nititham Joanne, Chang Monica, Catanese Joseph, Begovich Ann B, Brown Elizabeth E, Edberg Jeffrey C, McGwin Gerald, Alarcón Graciela S, Ramsey-Goldman Rosalind, Reveille John D, Vila Luis M, Petri Michelle, Kimberly Robert P, Feng Xuebing, Sun Lingyun, Shen Nan, Li Wei, Lu Jian-Xin, Wakeland Edward K, Li Quan-Zhen, Yang Wanling, Lau Yu-Lung, Liu Fei-Lan, Chang Deh-Ming, Yu Chack-Yung, Song Yeong W, Tsao Betty P, Criswell Lindsey A, |
| VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement. Ophthalmic genetics 2013 Jan . Demir HD, Ortak H, Sahin S, Ate? O, Benli I, Inan?r A |
| The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. Molecular biology reports 2012 Oct . Silan C, Dogan OT, Silan F, Kukulguven FM, Asgun HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O |
| Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
| An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol. Journal of thrombosis and haemostasis : JTH 2012 May 10 (5): 767-72. van Schie R M F, Babajeff A M V, Schalekamp T, Wessels J A M, le Cessie S, de Boer A, van der Meer F J M, van Meegen E, Verhoef T I, Rosendaal F R, Maitland-van der Zee A H, |
| Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users. Journal of thrombosis and haemostasis : JTH 2012 Apr 10 (4): 606-14. Verhoef T I, Redekop W K, Buikema M M, Schalekamp T, Van Der Meer F J M, Le Cessie S, Wessels J A M, Van Schie R M F, De Boer A, Teichert M, Visser L E, Maitland-Van Der Zee A H, |
| Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
| Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes. Journal of thrombosis and haemostasis : JTH 2011 Apr 9 (4): 711-8. Moreau C, Pautas E, Gouin-Thibault I, Golmard J-L, Mahé I, Mulot C, Loriot M-A, Siguret |
| Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. Journal of thrombosis and haemostasis : JTH 2011 Jan 9 (1): 109-18. Watzka M, Geisen C, Bevans C G, Sittinger K, Spohn G, Rost S, Seifried E, Müller C R, Oldenburg |
| [Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage]. Terapevticheski? arkhiv 2011 83 (6): 59-65. Vorob'eva N M, Panchenko E P, Dobrovol'ski? A B, Titaeva E V, Khasanova Z B, Konovalova N V, Postnov A Iu, Kirienko A |
| Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders. Annals of hematology 2010 Nov 89 (11): 1147-54. Antón Ana I, González-Conejero Rocio, Roldán Vanessa, Quiroga Teresa, Sánchez-Vega Beatriz, Corral Javier, Vicente Vicente, Mezzano Die |
| The association of protein S Tokushima-K196E with a risk of deep vein thrombosis. International journal of hematology 2010 Sep 92 (2): 302-5. Ikejiri Makoto, Wada Hideo, Sakamoto Yuko, Ito Naohiko, Nishioka Junji, Nakatani Kaname, Tsuji Akihiro, Yamada Norikazu, Nakamura Mashio, Ito Masaaki, Nobori Tsuto |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 02, 2022
- Content source: